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ABSTRACT 
p190RhoGAP is a GTPase-activating protein (GAP) known to regulate actin cytoskeleton 
dynamics by decreasing RhoGTP levels through activation the intrinsic GTPase activity of Rho. 
Although the GAP domain of p190RhoGAP stimulates the intrinsic GTPase activity of several 
Rho family members (Rho, Rac, Cdc42) under in vitro conditions, p190RhoGAP is generally 
regarded as a GAP for RhoA in the cell. The cellular RacGAP activity of the protein has not 
been proved directly. We have previously shown that the in vitro RacGAP and RhoGAP activity 
of p190RhoGAP was inversely regulated through a polybasic region of the protein. Here we 
provide evidence that p190RhoGAP shows remarkable GAP activity toward Rac also in the cell. 
The cellular RacGAP activity of p190RhoGAP requires an intact polybasic region adjacent to the 
GAP domain whereas the RhoGAP activity is inhibited by the same domain. Our data indicate 
that through its alternating RacGAP and RhoGAP activity, p190RhoGAP probably plays a more 
complex role in the Rac-Rho antagonism than it was realized earlier.  
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INTRODUCTION 
 
Rho family GTPases (Rac, Rho, Cdc42) are crucial regulators of the actin cytoskeleton and they 
are involved in the control of many different cellular processes, including adhesion, migration, 
and polarity (Bishop and Hall, 2000). Rho family GTPases are regulated by GTPase-activating 
proteins (GAPs), guanine nucleotide exchange factors (GEFs), and guanine nucleotide 
dissociation inhibitors (GDIs) (Burridge and Wennerberg, 2004). GAPs promote inactivation of 
GTPases by stimulating their relatively weak intrinsic GTP hydrolyzing activity thereby 
converting them to an inactive GDP bound form. One small G-protein can be regulated through 
many GAPs and one GAP can regulate several G-proteins. The number of potential GAPs of the 
Rho family is especially numerous (Bernards, 2003; Tcherkezian and Lamarche-Vane, 2007; 
Ligeti et al., 2012). p190RhoGAP (p190-A) and the closely related p190-B are among the most 
important regulators of RhoA and the actin cytoskeleton (Chang et al., 1995; Arthur and 
Burridge, 2001).  
p190RhoGAP is a 190 kDa multidomain protein that includes an amino-terminal GTP-
binding domain (GBD), a large middle domain with multiple protein-protein interaction motifs - 
for example several diphenylalanine (FF) motifs that bind RNA-binding proteins - and a 
carboxy-terminal GAP domain (Settleman et al., 1992b; Foster et al., 1994; Jiang et al., 2005). 
In vitro, p190RhoGAP is able to inactivate several Rho family GTPases, the GAP domain 
functions in a hierarchical fashion to activate the intrinsic GTPase activity of Rho, Rac and 
Cdc42 (Settleman et al., 1992a; Ridley et al., 1993). Ridley et al. showed that microinjected 
p190RhoGAP catalytic domain preferentially targeted Rho, and impaired Rho-dependent 
cytoskeleton re-arrangements (Ridley et al., 1993). These microinjection experiments have 
suggested that p190RhoGAP was specific for the Rho small G protein. 
Accumulating evidence underlines the importance of „regulation of regulators” (Bernards 
and Settleman, 2004; Ligeti and Settleman, 2006; Ligeti et al., 2012). In our previous study we 
have shown that different phospholipids can regulate the in vitro RacGAP and RhoGAP activity 
of p190RhoGAP in opposite direction. A polybasic region (PBR, amino acids 1213-1236) in 
which 11 out of 24 amino acids are of basic character (7 arginines and 4 lysines) allows binding 
to phospholipids through electrostatic interactions and plays a key role in the switch of substrate 
preference of p190RhoGAP (Ligeti et al., 2004; Ligeti and Settleman, 2006; Levay et al., 2009). 
The aim of the present investigation was to decide whether p190RhoGAP possessed any 
RacGAP activity and the PBR had any regulatory role under cellular conditions. 
 
 
RESULTS 
 
p190RhoGAP has PBR-dependent RacGAP activity in the cell 
To investigate the potential GAP activity of p190RhoGAP towards Rac1 in the cell we 
performed Rac GTPase activation assay. COS7 cells were transfected transiently with control 
EGFP-C1 vector or GFP-fused full length wild-type or mutant p190RhoGAP constructs (Figure 
1A). Cells transfected with wild type p190RhoGAP (p190-WT-GFP) showed a significant 
decrease in Rac1 activity. In the case of the GAP-deficient p190RhoGAP mutant (p190-RA-
GFP) there was no decrease in the amount of active Rac1 (Figure 1B,C). Thus, p190RhoGAP 
requires GAP catalytic domain to inhibit Rac1 small G protein. Interestingly p190RhoGAP with 
intact GAP domain but lacking the PBR (p190-∆PBR-GFP) was also unable to inhibit Rac1, 
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which suggests that the PBR is essential for the RacGAP activity of p190RhoGAP (Figure 
1B,C). Next we investigated the effect of the endogenous p190RhoGAP on the Rac activity and 
performed PAK precipitation experiments in p190RhoGAP +/+ and p190RhoGAP -/- mouse 
embryonic fibroblasts (MEFs) (Brouns et al., 2000). We have found that the amount of active 
Rac was significantly higher in p190RhoGAP -/- MEFs as compared to the p190RhoGAP +/+ MEF 
cells (Figure 1D,E). Taken together these results strongly suggest that p190RhoGAP is able to 
inhibit Rac1 in the cell and intact GAP domain and PBR are required for this function. 
 
p190RhoGAP inhibits membrane ruffling, a Rac-dependent cytoskeletal rearrangement 
Rac proteins are critical elements in the extracellular growth factor induced signalling pathway 
that leads eventually to membrane ruffling (Ridley et al., 1992). To confirm the RacGTPase 
activating effect of p190RhoGAP in the cell, we investigated the effect of wild type or mutant 
p190RhoGAP on the EGF-induced membrane ruffling in COS7 cells. We transiently transfected 
cells with GFP-tagged full-length wild type, GAP mutant and PBR mutant p190RhoGAP or 
control vector. As shown in Figure 2G-I and P, over-expression of wild type p190RhoGAP 
(p190-WT-GFP) abolished the EGF-induced ruffling whereas ruffling was observed on the cells 
transfected with the control vector (Figure 2D-F and P) or the GAP-deficient mutant (p190-RA-
GFP) (Figure 2J-L, and P). Interestingly, ruffling was not abolished in PBR mutant 
p190RhoGAP (p190-∆PBR-GFP) transfected cells (Figure 2, M-P) similar to the GAP-deficient 
mutant. Thus PBR seems to be important for inhibitory effect of p190RhoGAP on Rac-
dependent membrane ruffling.  
 
The PBR is not essential for the RhoGAP activity of p190RhoGAP 
In our previous work we have found that PBR played a key role in the switch between the 
RacGAP and RhoGAP activity of p190RhoGAP in vitro (Levay et al., 2009). To study the role 
of the PBR on the cellular RhoGAP activity of p190RhoGAP, we performed Rho GTPase 
activation assay in COS7 cells transfected transiently with control vector or p190RhoGAP 
constructs. As expected, wild type p190RhoGAP (p190-WT-GFP) decreased the amount of 
active Rho in the transfected cell to ~20% of the value detected in the control cells (Figure 3A-
B). There was no change in the amount of active Rho, when the cells were transfected with 
GAP-deficient p190RhoGAP mutant (p190-RA-GFP). The p190RhoGAP mutant lacking the 
PBR (p190-∆PBR-GFP) has shown an even higher RhoGAP activity than the wild type protein 
(remaining RhoGTP was ~5 resp. ~20% of the control value), however this change was 
statistically not significant (Figure 3B).  
Rho activity is known to correlate with stress fiber formation in the cell and 
p190RhoGAP is able to inhibit the Rho dependent stress fiber formation (Ridley and Hall, 1992; 
Chang et al., 1995). We investigated whether the abscence of the PBR of the protein can 
influence this function. COS7 cells were transfected transiently with control vector or 
p190RhoGAP constructs. LPA induced stress fiber formation in ~60% of the cells transfected 
with the control vector (Figure 4D-F and P). Cells transfected with wild type p190RhoGAP 
(p190-WT-GFP) showed reduced (9%) stress fiber formation, whereas in the cells transfected 
with the GAP mutant p190RhoGAP (p190-RA-GFP) the stress fiber formation was intact (Figure 
4J-L and P). The PBR mutant (p190-∆PBR-GFP) transfected cells showed reduced stress fiber 
formation similarly to the wild type p190RhoGAP transfected cells (Figure 4M-P). We can 
conclude that the PBR is not essential for the RhoGAP activity of p190RhoGAP.  
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The PBR inhibits the p190RhoGAP-induced multinucleation  
Overexpression of full length wild type p190RhoGAP almost completely decreased the amount 
of active Rho and abolished the stress fiber formation, so that a potential increase of RhoGAP 
activity could not be detected in these systems. Overexpression of p190RhoGAP causes 
multinucleation of the cells and it was shown that the RhoGAP activity of the protein is both 
necessary and sufficient to induce this phenotype (Manchinelly et al.; Su et al., 2003). We 
investigated whether overexpression of the PBR mutant p190RhoGAP has similar or different 
effect on multinucleation than the wild type protein. COS7 cells were transiently transfected with 
control vector or p190RhoGAP constructs. Quantification of the multinucleation phenotype 
showed that over-expression of the wild type p190RhoGAP (p190-WT-GFP) caused a higher 
multinucleation percentage (14%) than occurred in cells transfected with the control vector (8%), 
or with GAP-deficient p190RhoGAP (p190-RA-GFP) (7%). Interestingly, the PBR mutant 
(p190-∆PBR-GFP) was even more efficient than the wild type protein in causing multinucleation 
phenotype. The percentage of the multinucleated cells was significantly higher in cells 
overexpressing the PBR mutant (p190-∆PBR-GFP) (26%) as compared to the wild type 
p190RhoGAP transfected cells (Figure 5). This result strongly supports the hypothesis, that the 
PBR negatively regulates the RhoGAP activity of p190RhoGAP. 
 
 
DISCUSSION 
In our previous experiments we found that different acidic phospholipids were able to 
regulate the in vitro RacGAP and RhoGAP activity of p190RhoGAP reciprocally. The PBR 
domain (amino acids 1213-1236), located on the N-terminal side of the GAP domain played a 
key role in the substrate preference switch (Ligeti et al., 2004; Ligeti and Settleman, 2006; Levay 
et al., 2009). Our in vitro results apparently contradict to earlier data obtained in transfected cells 
(Ridley et al. 1993).  
Ridley et al. showed that the microinjected GAP domain (amino acids 1260-1469) of 
p190RhoGAP inhibited the Rho dependent stress fibres, but not the Rac dependent membrane 
ruffles (Ridley et al., 1993). This experiment suggested that p190RhoGAP is a Rho specific GAP 
in vivo. There are indications that p190RhoGAP is also able to inhibit Rac function in the cell. 
Zhang et al. suggest that although p190RhoGAP has higher affinity for Rho than Rac, the 
catalytic efficiency of p190RhoGAP for Rac is not substantially different from that of other 
known Rho family GAPs and thereby p190RhoGAP is capable of acting as a negative regulator 
for Rac-mediated signaling (Zhang et al., 1998). Tatsis et al. showed that the morphological 
changes caused by overexpression of p190RhoGAP could be suppressed not only by co-
expression of a gain-of-function Rho mutant, RhoA(G14V), but also by the gain-of-function Rac 
mutant, Rac1(G12V) (Tatsis et al., 1998). There are also other sporadic data suggesting that 
p190RhoGAP could be able to inhibit the Rac signaling pathway in different cell types 
(Heyworth et al., 1993; Coso et al., 1995; Threadgill et al., 1997) but no direct proof has been 
presented hitherto.  
In the present paper we demonstrate that overexpression of full length p190RhoGAP 
reduces the amount of GTP-bound Rac in COS7 cells. We also show that MEF cells lacking 
endogenous p190RhoGAP have higher Rac activity than the WT MEF cells. Overexpression of 
full length WT p190RhoGAP but not the GAP defective mutant was able to inhibit EGF induced 
membrane ruffling, a Rac dependent function in COS7 cells. These results support that 
p190RhoGAP possesses RacGAP activity also within the cell.  
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In the presented experiments we show that the RacGAP activity of p190RhoGAP is 
abolished in the mutant protein lacking the PBR, similar to the GAP-deficient mutant. Thus PBR 
is essential for the cellular RacGAP activity of p190RhoGAP. It is important to note that Ridley 
et al. used in the microinjected experiments the isolated GAP domain of p190RhoGAP which 
lacked the PBR. Therefore our present data are not inconsistent with the previous results of 
Ridley et al., but provide evidence that the full length p190RhoGAP is able to inhibit Rac small 
G-protein in the cell. 
In contrast to the RacGAP activity, the PBR is not essential for the RhoGAP activity of 
p190RhoGAP. The lack of the PBR even slightly enhanced the RhoGAP activity of 
p190RhoGAP in the Rho precipitation assay indicating an inhibitory effect of the PBR. This 
inhibitory effect was more prominent when we investigated the multinucleation phenotype 
caused by p190RhoGAP. Mitotic cell rounding is accompanied by changes in the actin 
cytoskeleton. High RhoGTP and low p190RhoGAP activity is required for cortical retraction 
during mitosis and for the successful completion of cytokinesis (Manchinelly et al.; Maddox and 
Burridge, 2003). Su et al. showed that p190RhoGAP is cell cycle regulated and overexpression 
of the protein resulted in a multinucleated phenotype that was dependent on the GAP domain (Su 
et al., 2003). Manchinelly et al. showed that the percentage of multinucleation phenotype was 
higher if the cells expressed the GAP domain of p190RhoGAP than if they expressed the full 
length protein (Manchinelly et al.). The possible explanation is an inhibitory region within the 
p190RhoGAP molecule. In our experiments, the percentage of multinucleation was significantly 
higher in the cells transfected with the PBR deficient p190RhoGAP, than in the cells transfected 
with wild type construct. Our results indicate an inhibitory action of PBR on the RhoGAP 
activity of p190RhoGAP. 
Antagonism of Rac and Rho activity is required for several vital biological functions such 
as neurite outgrowth, directed cell migration or cell-cell adhesion and p190RhoGAPs seem to 
play a significant role in these processes (Tatsis et al., 1998; Brouns et al., 2000; Nimnual et al., 
2003; Noren et al., 2003; Bradley et al., 2006; Wildenberg et al., 2006; Grande-Garcia et al., 
2007; Bass et al., 2008; Bustos et al., 2008). In many cell types, Rho activity is negatively 
regulated by Rac via generation of ROS, which inhibits the low molecular weight protein 
tyrosine phosphatase (LMWPTP) ensueing tyrosine phosphorylation of p190RhoGAP (Nimnual 
et al., 2003). Cadherin-mediated adhesion inhibits Rho activation via tyrosine phosphorylation 
and specific localization of p190RhoGAP too (Noren et al., 2003; Wildenberg et al., 2006). 
p190RhoGAP is also the convergence point of adhesion signals from integrin-α5β1 and 
syndecan-4 in Rac activation and Rho inhibition (Bass et al., 2008) and plays a role in the 
caveolin-1 mediated Rac-Rho antagonism (Grande-Garcia et al., 2007). Our results presume that 
the role of p190RhoGAP in the Rac-Rho antagonism is not only due to its RhoGAP function as 
known previously but also the altered RacGAP function of p190RhoGAP. Thus due to its 
variable substrate specificity, p190RhoGAP seems to play a more complex role in the Rac-Rho 
antagonism in the cell than it was previously described.  
In summary, we provide the first direct evidence that p190RhoGAP is able to decrease 
the activity of Rac in the cell. Furthermore, we demonstrate the regulatory role of the PBR that is 
required for the RacGAP activity but inhibits the RhoGAP activity of p190RhoGAP in the 
cellular environment.  
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MATERIALS AND METHODS 
 
Materials 
PfuTurbo DNA polymerase was purcased from Stratagene. Paraformaldehyde was from Sigma 
(St Louis, MO, USA). EGF was purchased from R&D Systems (Wiesbaden, Germany), LPA 
was from Cayman Chemical (Ann Arbor, MI, USA). Anti-p190A antibody and anti-Rac1 
antibody were from BD Transduction Laboratories (San Jose, CA, USA), anti-RhoA antibody 
was from Santa Cruz Biotechnology (Santa Cruz, CA, USA), anti-β-actin mAb was from Sigma. 
Horseradish peroxidase (HRP)-labeled anti-mouse IgG antibody was purchased from GE 
Healthcare BioScience (Uppsala, Sweden). Alexa Fluor 568–labeled phalloidin and 4',6-
Diamino-2-phenylindole dihydrochloride (DAPI) was obtained was from Invitrogen (Carlsbad, 
CA, USA).  
 
Plasmids for Transfection 
p190-WT-GFP and p190-∆PBR-GFP were constructed by first performing PCR on RcHAp190 
RhoGAP or RcHAp190 RhoGAP∆PBR (Hu and Settleman, 1997) and then subcloning the 
BspEI and EcoRI digested PCR product into the EGFP-C1 vector. Mutation of the critical 
arginine of the GAP domain for p190-RA-GFP construct was performed using QuickChange 
site-directed mutagenesis kit following the manufacturer’s instructions (Stratagene, La Jolla, CA, 
USA), the mutagenic primer pair was 5’-
CAGAAGGCATCTACGCGGTGAGCGGAAACAAG-3’, and 5’-
CTTGTTTCCGCTCACCGCGTAGATGCCTTCTG-3’. The mutant clones were verified by 
restriction enzyme mapping and DNA sequencing. 
 
Cell culture and transfection 
COS-7 cells, p190RhoGAP -/- mouse embryonic fibroblasts (MEFs) and p190RhoGAP +/+ MEFs 
were grown in Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen) supplemented with 
10% (w/v) fetal bovine serum, 50 units/mL penicillin and 50 µg/mL streptomycin in a 
humidified atmosphere of 5% CO2 at 37°C. Transient overnight transfection of COS7 cells with 
GFP-fused full length wild-type or mutant p190RhoGAP costructs or control EGFP-C1 vector, 
was performed using FugeneHD (Roche Applied Science, Penzberg, Germany) according to the 
manufacturer’s instructions. Cells were investigated 24-72 hours after transfection. 
 
Rho and Rac GTPase activation assay 
The cellular levels of GTP loaded RhoA and Rac1 were determined with pull-down assay using 
GST fusion proteins containing the Rho GTPase-binding domain of rhotekin (GST-RBD) or 
p21-activated kinase (PAK) (GST-PBD) as described (Ren and Schwartz, 2000; Benard and 
Bokoch, 2002). GST-RBD and GST-PBD have been expressed in Escherichia coli. For pull-
down, COS-7 cells were plated on 60 mm diameter culture dish, transiently transfected with 
GFP-fused full length wild-type or mutant p190RhoGAP and cultured for 48 h. The growth 
medium was replaced with medium containing 0,5% FCS 24 hours before the pull-down assay. 
The cells were activated with 10 ng/ml EGF for Rac activation or 5 µM LPA for Rho activation 
in serum free DMEM at 37°C for 20 min (EGF) or 5 min (LPA). The activation medium was 
removed carefully, then the cells were scraped in 500µl ice-cold pull-down lysis buffer (50 mM 
Tris-HCl, pH 7,4, 100 mM NaCl, 2 mM MgCl2, 10% (w/v) Glycerol, 1% (w/v) Nonidet P). Then 
the samples were collected and centrifuged at 16000 g for 5 min at 4 °C. From the supernatant 50 
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µl were taken out to check the total amount of the GTPase. The rest of the supernatant was 
transferred into tubes containing the RBD-GST-Glutathion-Sepharose or the PBD-GST-
Glutathion-Sepharose beads. The samples were shaked at 4°C for 1 h. After centrifugation at 
16000 g for 2 min, beads were washed twice with ice-cold pull-down lysis buffer. Bound 
proteins and lysates in Laemmli sample buffer were boiled at 95 °C for 5 min and run on 15% 
(w/v) polyacrylamide gels followed by transfer to nitrocellulose membranes and Western 
blotting with anti-RhoA or anti-Rac1 antibodies. NIH Image J software was used for 
densitometry analysis. 
 
Western Blot Experiments 
Nitrocellulose membranes were blocked in PBS containing 5% milk powder and 0.1% (w/v) 
Tween 20 for 1 h at room temperature. After incubating the membranes with the first antibody 
(anti p190-A antibody, anti-Rac1 antibody, anti Rho-A antibody in 1:1000 dilution, anti-β-actin 
mAb in 1:10000 dilution) for 1 h at room temperature, membranes were washed 5× in PBS 
containing 0.1% (w/v) Tween 20. Horseradish peroxidase-conjugated anti-mouse-Ig secondary 
antibody was used in 1:2000 dilution and signals were detected on FUJI Super RX films using 
the enhanced chemiluminescence method. 
 
Immunofluorescent experiments 
COS7 cells grown on glass coverslips in six-well plates were transiently transfected with GFP-
fused full length wild-type or mutant p190RhoGAP constructs or control vector and cultured for 
24-72 h. Stimulation was carried out with 10 ng/ml EGF for 20 min, or 5 µM LPA for 5 min. 
Cells were fixed with 4% (w/v) paraformaldehyde and permeabilized with 0.5% Triton X-100 
for 3 min. Actin was visualized by staining with Alexa 568-conjugated phalloidin for 30 min. 
Nuclei were stained for 5 min with DAPI. Mowiol antifade reagent was used before investigating 
the cells in confocal microscope. 
 
Confocal laser microscopy 
Cell images were captured with an LSM 510 Zeiss confocal laser scanning microscope using 40× 
1.3 numerical aperture plan Neofluar objective (Carl Zeiss). Excitation was with 25-milliwatt 
argon laser emitting 488 nm and a 1.0-milliwatt helium/neon laser emitting at 543 nm. Emissions 
were collected using a 500–530-nm band pass filter for GFP and a 560-nm long pass filter for 
Alexa568.  
 
Statistical analysis 
P values were determined by unpaired student’s t test and significance is indicated as follows: 
*** p ˂ 0.001, ** p ˂ 0.01, * p ˂ 0.05, and n.s. is p > 0.05. 
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FIGURE LEGENDS 
 
Figure 1. 
p190RhoGAP inhibits Rac small G-protein in RacGTPase activation assay, the RacGAP-activity 
requires PBR of p190RhoGAP. 
(A) Domain structure of wild type (p190-WT) and mutant (p190-RA, p190-∆PBR, p190-∆PBR-
RA) p190RhoGAP. GBD = GTP-binding domain, FF = FF domain, GAP = GAP domain, * = 
PBR (polybasic region, amino acids 1213-1236) (B) COS7 cells transiently expressing either 
GFP or GFP-tagged wild type or mutant p190RhoGAP constructs were treated with 10 ng/ml 
EGF for 20 min, lysed and mixed with PAK (GST-PBD) bound to glutathione-agarose beads to 
precipitate the active form of Rac1 small GTPase (Rac1-GTP). Bound active Rac1 was resolved 
on SDS-PAGE and detected by immunoblotting with anti Rac1 antibody as well as total Rac1. 
p190RhoGAP expression was analyzed by immunoblot with anti-p190A antibody, β-actin is 
shown as loading control. (C) Quantitation of Rac1-activation (Rac1-GTP/Total Rac1) in COS7 
cells. 100% corresponds to Rac1-GTP detected in cells transfected with control vector. Values 
are means +SEM (n=11,11,5,10,3), ***p<0.001. (D) Rac GTPase activation assay in 
p190RhoGAP +/+ (p190+/+) and p190RhoGAP -/- (p190-/-) mouse embryonal fibroblasts (MEFs). T 
= total Rac1 in cell lysates, P = precipitate of active Rac1 (Rac1-GTP). Presence of 
p190RhoGAP and β-actin as loading control were detected in cell lysates (T) by the antibodies 
described above. (E) Quantification of Rac1-activation in MEFs. 100% corresponds to Rac1-
GTP detected in p190RhoGAP +/+ cells. Values are means +SEM (n=5) 
 
Figure 2. 
p190RhoGAP inhibits EGF induced membrane ruffling, which requires GAP activity and intact 
PBR. 
(Panel A-O) COS7 cells were transfected with control vector, GFP-tagged wild type or mutant 
p190RhoGAP (green). Actin was stained with Alexa-568-labelled phalloidin (red). Ruffling is 
indicated by arrows. Stimulation was carried out with 10 ng/ml EGF for 20 min. (P) Quantitation 
of EGF-induced ruffling in COS7 cells. Percentage of ruffled cells from hundred transfected 
cells was calculated. Mean +SEM of n=7 (control vector, p190-WT-GFP, p190-∆PBR-GFP) or 
n=6 (p190-RA-GFP) experiments are shown. ***p<0.001. 
 
Figure 3. 
Effect of WT and mutant p190RhoGAP on the Rho activity in RhoGTPase activation assay. 
(A) Level of RhoA-GTP was analysed by RhoGTPase activation assay in transfected COS7 cells 
treated with 5 µM LPA for 5 min. The precipitates, and the control lysates were separated by 
SDS-PAGE and analyzed by Western blotting. Active RhoA (RhoA-GTP) and total RhoA were 
detected by immunoblotting with anti RhoA antibody, p190RhoGAP expression was analyzed by 
immunoblot with anti-p190A antibody, β-actin was used as loading control. (B) Quantitation of 
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RhoA-activation (RhoA-GTP/Total RhoA). 100% corresponds to RhoA-GTP detected in cells 
transfected with control vector. Values are means +SEM (n=3,4,3,5), ***p<0.001.  
 
Figure 4. 
Inhibition of LPA-induced stress fiber formation by p190RhoGAP in COS7 cells.  
(Panel A-O) COS7 cells were transfected with control vector, wild type or mutant p190RhoGAP 
(green). Actin was stained with Alexa-568-labelled phalloidin (red). Stimulation was carried out 
with 5 µM LPA for 5 min.  (P) Quantitation of LPA-induced stress fiber formation. Percentage 
of cells with stress fibers from hundred transfected cells was calculated. Mean +SEM of n=6 
(control vector, p190-WT-GFP, p190-RA-GFP) or n=4 (p190-∆PBR-GFP) experiments are 
shown. ***p<0.001.  
 
Figure 5. 
p190RhoGAP overexpression results in the multinucleation in COS7 cells. (Panel A-L) 
Multinucleation in control cells, in a p190-WT-GFP, p190-RA-GFP or p190-∆PBR-GFP 
transfected cells (green). Nuclei were stained blue with DAPI. (M) Quantitation of the 
percentage of multinucleation (nuclei ≥2) in 100 transfected cells. Values are means +SEM 
(n=5,8,5,8), *p<0.05, ***p<0.001. 
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